Registry study for NeoChord artificial mitral valve chord
Part of Heart & circulation clinical trials.
This study keeps track of people who had NeoChord treatment to help understand how well it works in everyday care. You may be included if you had a certain type of mitral valve leakage (regurgitation) and the procedure happened after 2016.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have mitral valve leakage that is Grade 3 (moderate) or Grade 4 (severe)
- Your mitral valve problem is caused by “wear and tear” (degenerative) or a mix of causes
- Your NeoChord procedure was completed after December 31, 2016
- Your valve is not described as heavily calcified (very hardened)
- You do not have an infection in the valve (active bacterial endocarditis)
- Your valve condition is not caused by a complex problem like leaflet perforation, or by inflammatory valve disease
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This registry collects health information from adults who already have the Carillon device to treat a leaky mitral valve caused by dilated heart muscle. The goal is to better understand how the device performs in real-world care over time.
This registry study follows people who are getting a minimally invasive heart valve repair called M-TEER. It helps doctors learn more about how well the procedure works and how patients recover.
This study collects and compares real-world results to help doctors choose the best treatment for mitral valve “leakiness.” If you have clinically significant mitral insufficiency and have already had a specific heart procedure screening, your echocardiogram results may be used to understand outcomes over at least a month.
This trial tests a new device to fix a leaky mitral valve without open-heart surgery. It is for people with severe mitral regurgitation who are too high-risk for traditional surgery.
This study keeps a registry of adults who have a mitral valve problem and are being evaluated for a catheter-based mitral valve replacement. It helps doctors understand what treatments are used and how patients do.
This trial focuses on people with severe mitral valve narrowing or leaking who still have symptoms even after the best usual medications. It may help find better care and measure health outcomes when surgery is judged too risky or not suitable.
Hear when a new Mitral Regurgitation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.